Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATryn in DIC associated with severe sepsis
NCT00506519Phase 2Terminated
- Sponsor
- LEO Pharma
- Start
- Jul 2007
- Primary completion
- Mar 2009
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 2 trial of antithrombin III in disseminated intravascular coagulation (DIC), sponsored by LEO Pharma. Started Jul 2007; status: terminated.
02
Drugs
antithrombin III
03
Conditions
disseminated intravascular coagulation (DIC)
Beyond the preview
Go deeper on NCT00506519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00506519.